These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3497136)

  • 1. [Classification of progressive systemic scleroderma].
    Holzmann H; Sollberg S; Altmeyer P
    Hautarzt; 1987 May; 38(5):253-7. PubMed ID: 3497136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].
    Goerz G; Hammer G; Wirth G; Hornstein OP; Keller GJ; Altmeyer P; Holzmann H; Meigel W; Mensing H; Braun-Falco O
    Hautarzt; 1986 Jun; 37(6):320-4. PubMed ID: 3522484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunology and clinical picture of progressive scleroderma].
    Sönnichsen N
    Z Hautkr; 1985 Dec; 60(23):1829-30, 1833-4. PubMed ID: 2936012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
    Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
    J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 6. Criteria for the classification of early systemic sclerosis.
    LeRoy EC; Medsger TA
    J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.
    Poirier TJ; Rankin GB
    Am J Gastroenterol; 1972 Jul; 58(1):30-44. PubMed ID: 4537959
    [No Abstract]   [Full Text] [Related]  

  • 9. Case control study of antibodies to ENA in progressive systemic sclerosis patients.
    Furst DE; Obrodovic M; Barnett EV; Clements PJ; Paulus HE
    J Rheumatol; 1984 Jun; 11(3):298-305. PubMed ID: 6610753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of scleroderma and pseudoscleroderma.
    Fabri M; Hunzelmann N
    J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of scleroderma.
    LeRoy EC; Lomeo R
    Hosp Pract (Off Ed); 1989 Oct; 24(10A):33-42 contd. PubMed ID: 2509491
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody pattern and other criteria for diagnosis and classification in PSS.
    Burgos-Vargas R; Martínez-Cordero E; Reyes-López PA; Herrera-Esparza R
    J Rheumatol; 1988 Jan; 15(1):153-4. PubMed ID: 3258382
    [No Abstract]   [Full Text] [Related]  

  • 13. [General practice-relevant diagnostic and differential diagnostic aspects of collagen diseases. Sclerodermia progressiva, dermatomyositis and periarteritis nodosa].
    Apostoloff E; Sönnichsen N
    Z Arztl Fortbild (Jena); 1987; 81(8):388-91. PubMed ID: 2887075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antinuclear antibodies as early diagnostic criteria of developing collagen disease in quartz dust exposure--a case report].
    Mehlhorn J; Conrad K; Frank KH; Ziegler H; Harzbecker K; Ullmann L; Lüthke K
    Z Gesamte Inn Med; 1990 Mar; 45(3):68-71. PubMed ID: 2159677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA in systemic scleroderma (PSS) and familial scleroderma.
    Sasaki T; Denpo K; Ono H; Nakajima H
    J Dermatol; 1991 Jan; 18(1):18-24. PubMed ID: 2050902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progressive systemic sclerosis without cutaneous involvement].
    Pereira RM; Missi SM; Thomazini E; Yoshinari NH
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):144-7. PubMed ID: 3494294
    [No Abstract]   [Full Text] [Related]  

  • 19. [Association of HLA antigens with scleroderma].
    Kühnl P; Schütz K; Altmeyer P; Holzmann H; Seidl S
    Z Hautkr; 1985 Jun; 60(11):866-8. PubMed ID: 3892952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.